Free Trial
NASDAQ:BHST

BioHarvest Sciences Q2 2025 Earnings Report

BioHarvest Sciences logo
$8.10 +0.20 (+2.53%)
As of 08/7/2025 03:26 PM Eastern

BioHarvest Sciences EPS Results

Actual EPS
N/A
Consensus EPS
-$0.11
Beat/Miss
N/A
One Year Ago EPS
N/A

BioHarvest Sciences Revenue Results

Actual Revenue
N/A
Expected Revenue
$8.53 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

BioHarvest Sciences Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Monday, August 11, 2025
Conference Call Time
8:00AM ET

Conference Call Resources

BioHarvest Sciences Earnings Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
See More BioHarvest Sciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioHarvest Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioHarvest Sciences and other key companies, straight to your email.

About BioHarvest Sciences

BioHarvest Sciences (NASDAQ:BHST) is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.

View BioHarvest Sciences Profile

More Earnings Resources from MarketBeat